Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose estetrol in healthy men
NL-OMON43503Phase 1Active, not recruiting
- Sponsor
- Pantarhei Oncology
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in prostate cancer (PCa) comparing Estetrol with Placebo (2 arms). Primary endpoints: Safety of multiple dosages of estetrol and Efficacy on hormone levels related to prostate function. Started Apr 2016; status: active, not recruiting.
02
Drugs
estetrol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON43503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43503.